N-Acetyl Sulfadiazine-13C6
|
- $215 - $2620
- Product name: N-Acetyl Sulfadiazine-13C6
- CAS: 1217089-17-2
- MF: C12H12N4O3S
- MW: 292.31368
- EINECS:
- MDL Number:
- Synonyms:N-Acetyl Sulfadiazine-13C6;2-[(p-AcetaMidophenyl-13C6)sulfonaMido]pyriMidine;4'-(2-PyriMidinylsulfaMoyl)acetanilide-13C6;4N-Acetylsulfadiazine-13C6;N-[4-[(2-PyriMidinylaMino)sulfonyl]phenyl-13C6]acetaMide;N4-Acetylsulfadiazine-13C6
4 prices
Selected condition：
Brand
- Medical Isotopes, Inc.
- TRC
- Usbiological
Package
- 2.5mg
- 5mg
- 50mg
- ManufacturerMedical Isotopes, Inc.
- Product numberC19292
- Product descriptionN-Acetylsulfadiazine-13C6
- Packaging5mg
- Price$890
- Updated2021-12-16
- Buy
- ManufacturerMedical Isotopes, Inc.
- Product numberC19292
- Product descriptionN-Acetylsulfadiazine-13C6
- Packaging50mg
- Price$2620
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberA187813
- Product descriptionN-AcetylSulfadiazine-13C6
- Packaging2.5mg
- Price$215
- Updated2021-12-16
- Buy
- ManufacturerUsbiological
- Product number001564
- Product descriptionN-Acetyl Sulfadiazine-13C6
- Packaging2.5mg
- Price$496
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Medical Isotopes, Inc. | C19292 | N-Acetylsulfadiazine-13C6 | 5mg | $890 | 2021-12-16 | Buy |
| Medical Isotopes, Inc. | C19292 | N-Acetylsulfadiazine-13C6 | 50mg | $2620 | 2021-12-16 | Buy |
| TRC | A187813 | N-AcetylSulfadiazine-13C6 | 2.5mg | $215 | 2021-12-16 | Buy |
| Usbiological | 001564 | N-Acetyl Sulfadiazine-13C6 | 2.5mg | $496 | 2021-12-16 | Buy |
Properties
Melting point :251-254°C
storage temp. :-20°C Freezer
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
color :White to Off-White
storage temp. :-20°C Freezer
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
color :White to Off-White
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|